Role of Neuronal NOS & Superoxide in Neurodegeneration

神经元 NOS 的作用

基本信息

  • 批准号:
    7201577
  • 负责人:
  • 金额:
    $ 32.89万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2000
  • 资助国家:
    美国
  • 起止时间:
    2000-04-10 至 2009-01-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Long-term goal: The broad objectives of this renewal are to understand the mechanism(s) by which mitochondrial neurotoxins such as 1-methyl-4-phenylpyridinium (MPP+) selectively destroy dopaminergic neurons in the substantia nigra, leading to the development of Parkinson's disease (PD). Reactive oxygen and nitrogen species (ROS/RNS)-mediated damage has been implicated in age-related neurodegenerative diseases like PD. Hypothesis: (i) MPP+ generates mitochondria superoxide (02*) and hydrogen peroxide (H202), and inactivates mitochondrial iron-sulfur-proteins (e.g., aconitase). This stimulates transferrin receptor (TfR)-mediated uptake of iron. (ii) MPP+-induced H202 and iron transported through TfR cause enhanced degradation of tetrahydrobiopterin (BH4), an essential co-factor for neuronal nitric oxide synthase (nNOS), tyrosine hydroxylase (TH), and dihydropteridine reductase (DHPR) activities. BH, depletion causes "uncoupling" of nNOS to form O2* and inactivation of TH and DHPR leading to dopamine depletion. (iii) MPP+-induced O2*, H2O2, and Tf-iron stimulate aggregation of a-synuclein, a neuronal presynaptic protein leading to apoptosis or programmed cell death. Aims: 1.) Investigate the effect of TfR-dependent iron and mitochondrial ROS in neuronal cell apoptosis in response to MPP+. 2.) Assess the modulatory effect of BH4 depletion on nNOS-generated nitric oxide ('NO)/O2* ratio and on BH4-dependent enzyme controlling dopamine synthesis. 3.) Elucidate the role of ROS, Tf-iron and BH4 depletion on a-synuclein aggregation and apoptosis in neuronal cells treated with MPP+. Methods: We will use both dopaminergic and non-dopaminergic cells (neuroblastoma and cerebellar granule neurons). The following redox-parameters will be measured: GSH and lipid peroxides; aconitase, complex-I, and iron-regulatory activities; TfR expression and 55Fe uptake; a-synuclein expression and aggregation; caspase activation and apoptosis. ROS/RNS will be determined by fluorescence and spin-trapping techniques. Significance: PD affects about 1% of population over the age of 50. Emerging data allude to environmental mitochondrial toxins as a causative factor. Novelty: This proposal sheds new light on the synergistic role for MPP*-induced mitochondrial ROS, iron, BH4-induced nNOS uncoupling, dopamine depletion and alpha-synuclein aggregation in neuronal toxicity of PD and other mitochondrial diseases.
描述(申请人提供):长期目标:这种更新的广泛目标是了解线粒体神经毒素(如1-甲基-4-苯基吡啶铵(MPP+))的机制,有选择地破坏了paskine nigra的多巴胺能神经元,导致了帕克森病(Parkinson's Diseal)(pds)的发展。活性氧和氮种(ROS/RNS)介导的损伤与年龄相关的神经退行性疾病(如PD)有关。假设:(i)MPP+产生线粒体超氧化物(02*)和过氧化氢(H202),并使线粒体铁硫蛋白(例如刺刺酶)失活。这刺激了铁蛋白受体(TFR)介导的铁的摄取。 (ii)MPP+诱导的H202和铁通过TFR转运的铁导致四氢无生蛋白的降解(BH4),这是神经元氧化物氧化物合酶(NNOS),酪氨酸羟化酶(TH)和二羟基替氏肽(Dihydropteridine reductase(Dhydihydropperidine reductase)(Dhydihydrobioptasise(NNOS)的必不可少的辅助因子)。 BH,耗尽会导致NNO的“解偶联”形成O2*,并使Th和DHPR灭活导致多巴胺消耗。 (iii)MPP+诱导的O2*,H2O2和TF铁刺激A-突触核蛋白的聚集,这是一种神经元突触前蛋白,导致细胞凋亡或程序性细胞死亡。目的:1。)研究响应MPP+的TFR依赖性铁和线粒体ROS对神经元细胞凋亡的影响。 2.)评估BH4耗竭对NNOS生成的一氧化氮('no)/O2*比率以及控制多巴胺合成的BH4依赖性酶的调节作用。 3.)阐明ROS,TF铁和BH4耗竭在用MPP+处理的神经元细胞中A核蛋白聚集和凋亡中的作用。方法:我们将同时使用多巴胺能和非多巴胺能细胞(神经细胞瘤和小脑颗粒神经元)。将测量以下氧化还原参数:GSH和脂质过氧化物; a刺酶,复合物I和铁调节活性; TFR表达和55FE吸收; A核蛋白的表达和聚集;胱天冬酶激活和凋亡。 ROS/RNS将由荧光和自旋陷阱技术确定。意义:PD在50岁以上影响约1%的人口。新兴数据将环境线粒体毒素称为致病因素。新颖性:该提案为MPP*诱导的线粒体ROS,铁,BH4诱导的NNOS解偶联,多巴胺耗竭和α-链核蛋白聚集在PD和其他线粒体疾病中的神经元毒性中介绍了新的启示。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

BALARAMAN KALYANARAMAN其他文献

BALARAMAN KALYANARAMAN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('BALARAMAN KALYANARAMAN', 18)}}的其他基金

Chemoprevention of lung cancer by targeting lonidamine to mitochondria
通过将氯尼达明靶向线粒体来化学预防肺癌
  • 批准号:
    9763831
  • 财政年份:
    2019
  • 资助金额:
    $ 32.89万
  • 项目类别:
Chemoprevention of lung cancer by targeting lonidamine to mitochondria
通过将氯尼达明靶向线粒体来化学预防肺癌
  • 批准号:
    9915863
  • 财政年份:
    2019
  • 资助金额:
    $ 32.89万
  • 项目类别:
Chemoprevention of lung cancer by targeting lonidamine to mitochondria
通过将氯尼达明靶向线粒体来化学预防肺癌
  • 批准号:
    10489835
  • 财政年份:
    2019
  • 资助金额:
    $ 32.89万
  • 项目类别:
Chemoprevention of lung cancer by targeting lonidamine to mitochondria
通过将氯尼达明靶向线粒体来化学预防肺癌
  • 批准号:
    10687020
  • 财政年份:
    2019
  • 资助金额:
    $ 32.89万
  • 项目类别:
Chemoprevention of lung cancer by targeting lonidamine to mitochondria
通过将氯尼达明靶向线粒体来化学预防肺癌
  • 批准号:
    10476701
  • 财政年份:
    2019
  • 资助金额:
    $ 32.89万
  • 项目类别:
Chemoprevention of Lung Cancer with Mitochondria-Targeted Honokiol
利用线粒体靶向和厚朴酚化学预防肺癌
  • 批准号:
    10497449
  • 财政年份:
    2017
  • 资助金额:
    $ 32.89万
  • 项目类别:
Chemoprevention of lung cancer with mitochondria-targeted honokiol
线粒体靶向和厚朴酚对肺癌的化学预防
  • 批准号:
    10092125
  • 财政年份:
    2017
  • 资助金额:
    $ 32.89万
  • 项目类别:
Mitochondria-targeted Agents in Breast Cancer
乳腺癌中的线粒体靶向药物
  • 批准号:
    8453421
  • 财政年份:
    2010
  • 资助金额:
    $ 32.89万
  • 项目类别:
EPR 2010
EPR 2010
  • 批准号:
    7912542
  • 财政年份:
    2010
  • 资助金额:
    $ 32.89万
  • 项目类别:
Mitochondria-targeted Agents in Breast Cancer
乳腺癌中的线粒体靶向药物
  • 批准号:
    8271285
  • 财政年份:
    2010
  • 资助金额:
    $ 32.89万
  • 项目类别:

相似海外基金

Mitochondrial mechanisms of redox cycling agents
氧化还原循环剂的线粒体机制
  • 批准号:
    8196945
  • 财政年份:
    2003
  • 资助金额:
    $ 32.89万
  • 项目类别:
Mitochondrial mechanisms of redox cycling agents
氧化还原循环剂的线粒体机制
  • 批准号:
    7588662
  • 财政年份:
    2003
  • 资助金额:
    $ 32.89万
  • 项目类别:
Mitochondrial mechanisms of redox cycling agents
氧化还原循环剂的线粒体机制
  • 批准号:
    8385547
  • 财政年份:
    2003
  • 资助金额:
    $ 32.89万
  • 项目类别:
Mitochondrial mechanisms of redox cycling agents
氧化还原循环剂的线粒体机制
  • 批准号:
    7999249
  • 财政年份:
    2003
  • 资助金额:
    $ 32.89万
  • 项目类别:
Mitochondrial mechanisms of redox cycling agents
氧化还原循环剂的线粒体机制
  • 批准号:
    7694259
  • 财政年份:
    2003
  • 资助金额:
    $ 32.89万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了